Lucid Group (LCID 4.73%) recently dropped its turnaround into another gear when it announced it had hired a new CEO to take ...

In just a few short months, Marathon has minted a highly quotable line: “Escape will make me God.” It’s also, according to ...

Lucid Group missed expectations for ⁠first-quarter vehicle deliveries on Friday, hurt by a temporary sales halt and recall tied to an unauthorized supplier change. Deliveries of its electric luxury ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. On paper, shares of EV companies should be rising. As gas ...

Lucid Motors has debuted a robotaxi concept vehicle that it’s calling the “Lucid Lunar,” which it showed off at an investor day on Thursday in New York City. It’s a two-seater vehicle with no steering ...

This is read by an automated voice. Please report any issues or inconsistencies here. Lucid, the Bay Area-based automaker that sells luxury electric vehicles, is laying off 319 workers as it sustains ...

Lucid Motors is laying off 12% of its workforce in a bid to “improve operational effectiveness and optimize our resources as we continue on our path toward profitability,” according to an internal ...

The most prominent feature of the new Gravity robotaxis is the “purpose-built roof-mounted halo,” which looks a lot more elegant than your average Waymo, and includes technology like lidar, ...

The companies said on-road testing began in December, led by Nuro using engineering prototypes supervised by safety operators, a move toward a planned robotaxi launch in the San Francisco Bay Area ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Lucid Group plans to start ...

Lucid’s Recharged certified used-car program offers inspected, warrantied Air sedans at deep discounts versus new, quietly acknowledging how fast the brand’s luxury EVs lose value while trying to turn ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...